发明名称 GLYCINE TRANSPORTER INHIBITOR
摘要 <p>The purpose of the present invention is to provide a novel compound, or a medically acceptable salt thereof, which is useful in the prevention or treatment of conditions such as schizophrenia, Alzheimer's disease, cognitive disorders, dementia, anxiety disorders (such as general anxiety disorder, panic disorder, obsessive-compulsive disorder, social anxiety disorder, post-traumatic stress disorder, specific phobias, and acute stress disorder), depression, drug dependency, convulsions, tremors, aches, or sleep disorders, on the basis of having inhibitory action on glycine uptake. A compound represented by formula [1] or a medically acceptable salt thereof.</p>
申请公布号 WO2012036278(A1) 申请公布日期 2012.03.22
申请号 WO2011JP71241 申请日期 2011.09.16
申请人 TAISHO PHARMACEUTICAL CO., LTD.;MORIYA, MINORU;YASUHARA, AKITO;SAKAGAMI, KAZUNARI;OHTA, HIROSHI;ABE, KUMI;YAMAMOTO, SHUJI;ARAKI, YUKO;URABE, HIROKI;SUN, XIANG-MIN 发明人 MORIYA, MINORU;YASUHARA, AKITO;SAKAGAMI, KAZUNARI;OHTA, HIROSHI;ABE, KUMI;YAMAMOTO, SHUJI;ARAKI, YUKO;URABE, HIROKI;SUN, XIANG-MIN
分类号 C07D233/90;A61K31/4178;A61K31/4196;A61K31/422;A61K31/4245;A61K31/427;A61K31/437;A61K31/4439;A61K31/444;A61K31/4709;A61K31/4725;A61K31/497;A61K31/506;A61K31/5377;A61P25/04;A61P25/08;A61P25/14;A61P25/18;A61P25/20;A61P25/22;A61P25/24;A61P25/28;A61P25/36;C07D401/12;C07D401/14;C07D403/12;C07D405/12;C07D405/14;C07D409/12;C07D413/12;C07D417/12;C07D417/14;C07D471/04 主分类号 C07D233/90
代理机构 代理人
主权项
地址